Assess the Efficacy and Safety of Multi-target Therapy in Lupus Nephritis

NCT00876616 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

362

Enrollment

OTHER

Sponsor class

Conditions

Lupus Nephritis

Interventions

DRUG: Tacrolimus+Mycophenolate mofetil
DRUG: Cyclophosphamide

Sponsor

Zhi-Hong Liu, M.D.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]